Ligand Pharmaceuticals Incorporated - Investor Relations
Dec 18, 2025 · Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value …
About Us - Ligand Pharmaceuticals
Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value programs that can …
Ligand Pharmaceuticals - Biopharma's Technology and Capital Partner
Ligand invests in the clinical development and commercialization of high-value medicines. We manage one of the largest and most diverse portfolios of biopharmaceutical royalties in the industry, with …
Ligand Reports First Quarter 2025 Financial Results
May 8, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, …
Ligand and Medtronic Commit $70 Million in Strategic Capital to ...
Jul 31, 2025 · Ligand’s decision to invest in our partnered programs and our team reflects our shared conviction in the transformative potential of both AVIM therapy and Virtue SAB—our late-stage …
Ligand Pharmaceuticals Incorporated - Ligand to Report Fourth …
Feb 12, 2026 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, …
Ligand Pharmaceuticals Incorporated - Stock Info
Dec 11, 2023 · All 3m NASDAQ:LGND News Releases Nov 24 Dec 1 Dec 8 Dec 15 Dec 22 Jan 5 Jan 12 Jan 19 Jan 26 Feb 2 Feb 9 Feb 16 2021 2022 2023 2024 2025 2026 170 180 190 200 210 0 ...
Ligand Announces Completion of Pelthos Therapeutics Merger with …
Jul 2, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, …
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
Nov 6, 2025 · Ligand does this by providing financing, licensing our technologies or both. Our business model seeks to generate value for stockholders by creating a diversified portfolio of biotech and …
Royalty Portfolio - Ligand Pharmaceuticals
Attractive programs with high clinical value. Today, Ligand manages one of the largest and most diverse portfolios of biopharmaceutical royalties in the industry, with more than 100 partnered commercial …